News
Oral presentation of CARTITUDE-1 study data showcases long-term outcomes after a single infusion of CARVYKTI® with one-third of patients with relapsed/refractory multiple myeloma progression-free for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback